144 related articles for article (PubMed ID: 33198388)
1. Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation.
Rivera-Caravaca JM; Teruel-Montoya R; Roldán V; Cifuentes-Riquelme R; Crespo-Matas JA; de Los Reyes-García AM; Águila S; Fernández-Pérez MP; Reguilón-Gallego L; Zapata-Martínez L; García-Barberá N; Vicente V; Marín F; Martínez C; González-Conejero R
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33198388
[No Abstract] [Full Text] [Related]
2. Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry.
Ding WY; Fawzy AM; Romiti GF; Proietti M; Pastori D; Huisman MV; Lip GYH;
J Thromb Thrombolysis; 2024 Jan; 57(1):39-49. PubMed ID: 37566295
[TBL] [Abstract][Full Text] [Related]
3. Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score.
Polovina M; Đikić D; Vlajković A; Vilotijević M; Milinković I; Ašanin M; Ostojić M; Coats AJS; Seferović PM
Int J Cardiol; 2017 Dec; 249():191-197. PubMed ID: 28986061
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation.
Rivera-Caravaca JM; Marín F; Esteve-Pastor MA; Raña-Míguez P; Anguita M; Muñiz J; Cequier Á; Bertomeu-Martínez V; Valdés M; Vicente V; Lip GYH; Roldán V
Am J Cardiol; 2017 Dec; 120(12):2176-2181. PubMed ID: 29111209
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score.
Pastori D; Farcomeni A; Poli D; Antonucci E; Angelico F; Del Ben M; Cangemi R; Tanzilli G; Lip GY; Pignatelli P; Violi F
Intern Emerg Med; 2016 Mar; 11(2):199-204. PubMed ID: 26471883
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study.
Sanmartín Fernández M; Anguita Sánchez M; Arribas F; Barón-Esquivias G; Barrios V; Cosin-Sales J; Esteve-Pastor MA; Freixa-Pamias R; Lekuona I; Pérez-Cabeza AI; Ureña I; Vázquez Rodríguez JM; Rafols Priu C; Marin F
Cardiol J; 2022; 29(4):601-609. PubMed ID: 35621092
[TBL] [Abstract][Full Text] [Related]
7. miR-146a-5p, miR-223-3p and miR-142-3p as Potential Predictors of Major Adverse Cardiac Events in Young Patients with Acute ST Elevation Myocardial Infarction-Added Value over Left Ventricular Myocardial Work Indices.
Scărlătescu AI; Barbălată T; Sima AV; Stancu C; Niculescu LȘ; Micheu MM
Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010296
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients.
Pastori D; Rivera-Caravaca JM; Esteve-Pastor MA; Roldán V; Marín F; Pignatelli P; Violi F; Lip GYH
Circ J; 2018 Apr; 82(5):1286-1292. PubMed ID: 29553090
[TBL] [Abstract][Full Text] [Related]
9. Effects of Atrial Fibrillation and Chronic Kidney Disease on Major Adverse Cardiovascular Events.
Ding WY; Lip GYH; Pastori D; Shantsila A
Am J Cardiol; 2020 Oct; 132():72-78. PubMed ID: 32773222
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of the 2MACE score as a predictor of long-term all-cause mortality in patients with atrial fibrillation.
Szymańska A; Płatek AE; Semczuk-Kaczmarek K; Szymański FM; Dłużniewski M
Pol Arch Intern Med; 2020 Aug; 130(7-8):635-639. PubMed ID: 32539310
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA Together with miR-142-3p in Plasma Can Predict Unfavorable Outcomes in Patients after Acute Myocardial Infarction.
Barbalata T; Scarlatescu AI; Sanda GM; Toma L; Stancu CS; Dorobantu M; Micheu MM; Sima AV; Niculescu LS
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077347
[TBL] [Abstract][Full Text] [Related]
12. Exploratory Analysis of Circulating miRNA Signatures in Atrial Fibrillation Patients Determining Potential Biomarkers to Support Decision-Making in Anticoagulation and Catheter Ablation.
Kiyosawa N; Watanabe K; Morishima Y; Yamashita T; Yagi N; Arita T; Otsuka T; Suzuki S
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32244749
[TBL] [Abstract][Full Text] [Related]
13. Combined Analysis of Human and Experimental Murine Samples Identified Novel Circulating MicroRNAs as Biomarkers for Atrial Fibrillation.
Natsume Y; Oaku K; Takahashi K; Nakamura W; Oono A; Hamada S; Yamazoe M; Ihara K; Sasaki T; Goya M; Hirao K; Furukawa T; Sasano T
Circ J; 2018 Mar; 82(4):965-973. PubMed ID: 29398686
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
[TBL] [Abstract][Full Text] [Related]
15. [Radiofrequency ablation can reverse the abnormal circulating microRNA expression changes in patients with atrial fibrillation].
Cui Y; Su Y; Li L; Zhao S; Nan J; Yue Y; Yang S
Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Dec; 43(12):1051-6. PubMed ID: 26888839
[TBL] [Abstract][Full Text] [Related]
16. Predictive Inflammation-related microRNAs for Cardiovascular Events Following Early-Onset Coronary Artery Disease.
Ziaee S; Hosseindokht M; Cheraghi S; Pourgholi L; Ahmadi A; Sadeghian S; Abbasi SH; Davarpasand T; Boroumand M
Arch Med Res; 2021 Jan; 52(1):69-75. PubMed ID: 33261889
[TBL] [Abstract][Full Text] [Related]
17. Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project.
Rivera-Caravaca JM; Roldán V; Romera M; Esteve-Pastor MA; Valdés M; Lip GYH; Vicente V; Marín F
J Gen Intern Med; 2018 Jun; 33(6):847-854. PubMed ID: 29569024
[TBL] [Abstract][Full Text] [Related]
18. Circulating MiR-19b-3p, MiR-134-5p and MiR-186-5p are Promising Novel Biomarkers for Early Diagnosis of Acute Myocardial Infarction.
Wang KJ; Zhao X; Liu YZ; Zeng QT; Mao XB; Li SN; Zhang M; Jiang C; Zhou Y; Qian C; Feng KG; Guan HQ; Tang TT; Cheng X; Chen ZJ
Cell Physiol Biochem; 2016; 38(3):1015-29. PubMed ID: 26939053
[TBL] [Abstract][Full Text] [Related]
19. Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation.
Nopp S; van der Bent ML; Kraemmer D; Königsbrügge O; Wojta J; Pabinger I; Ay C; Nossent AY
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835272
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-132, miR-146a, and miR-155 as potential biomarkers of methotrexate response in patients with rheumatoid arthritis.
Singh A; Patro PS; Aggarwal A
Clin Rheumatol; 2019 Mar; 38(3):877-884. PubMed ID: 30511295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
